| Literature DB >> 31433698 |
Christopher G Kevil1,2,3, Nicholas E Goeders4, Matthew D Woolard5, Md Shenuarin Bhuiyan1,2, Paari Dominic6, Gopi K Kolluru1, Connie L Arnold6, James G Traylor1, A Wayne Orr1,2,3.
Abstract
While the opioid epidemic has garnered significant attention, the use of methamphetamines is growing worldwide independent of wealth or region. Following overdose and accidents, the leading cause of death in methamphetamine users is cardiovascular disease, because of significant effects of methamphetamine on vasoconstriction, pulmonary hypertension, atherosclerotic plaque formation, cardiac arrhythmias, and cardiomyopathy. In this review, we examine the current literature on methamphetamine-induced changes in cardiovascular health, discuss the potential mechanisms regulating these varied effects, and highlight our deficiencies in understanding how to treat methamphetamine-associated cardiovascular dysfunction.Entities:
Keywords: atherosclerosis; cardiac arrhythmias; cardiomyopathy; methamphetamine; pulmonary hypertension; substance-related disorders; vasoconstriction
Mesh:
Substances:
Year: 2019 PMID: 31433698 PMCID: PMC6709697 DOI: 10.1161/ATVBAHA.119.312461
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 8.311